Emanuel José Saad1, María Antonella Correa Barovero2, Federico Ariel Marucco3, Silvina Trinidad Rodríguez Bonazzi4, Ayelén Tarditi Barra5, Melani Zlotogora6, Sofía María Villada7, Augusto Douthat Y Barrionuevo8, María Celeste Heredia9, Juan Pablo Caeiro10, Pehuén Fernández11, Ricardo Arturo Albertini12. 1. Hospital Privado universitario de Córdoba. emanuelsaad@hotmail.com. 2. Hospital Privado Universitario de Córdoba. antocorrea77@gmail.com. 3. Hospital Privado Universitario de Córdoba, Instituto universitario de Ciencias Biomédicas de Córdoba. fedemarucco79@gmail.com. 4. Hospital Privado Universitario de Córdoba. silvitrb@gmail.com. 5. Hospital Privado Universitario de Córdoba. ayetarditi@gmail.com. 6. Hospital Privado Universitario de Córdoba. melizloto@gmail.com. 7. Hospital Privado Universitario de Córdoba. sofivillada14@gmail.com. 8. Hospital Privado Universitario de Córdoba. douthataug@gmail.com. 9. Hospital Privado Universitario de Córdoba, Instituto universitario de Ciencias Biomédicas de Córdoba. celesteheredia62@gmail.com. 10. Hospital Privado Universitario de Córdoba, Instituto universitario de Ciencias Biomédicas de Córdoba. jpcaeiro3@gmail.com. 11. Hospital Privado Universitario de Córdoba, Instituto Universitario de Ciencias Biomédicas de Córdoba. pehuenfernandez@hotmail.com. 12. Hospital Privado Universitario de Córdoba, Instituto Universitario de Ciencias Biomédicas de Córdoba. ricartualbertini@hotmail.com.
Abstract
Introduction: COVID-19 disease shows a marked heterogeneity in its clinical course, with descriptions of some factors associated with a worse prognosis. Knowledge of the disease behavior in the local scenario is relevant to allow a better approach. Methods: Retrospective study in two hospitals in the city of Córdoba, Argentina, with patients aged 18 years or more, hospitalized for active SARS-CoV-2 infection, from March to October, 2020. Results: 448 patients were included, of which 95.75% corresponded to COVID-19 pneumonia. Most of the episodes occurred in men (63.6%), the median age was 63 years (IQR: 53-75), and the most frequent comorbidities were arterial hypertension (55.1%), obesity (31.7%) and diabetes mellitus (28.1%). 162 patients (36.2%) needed admission to the intensive care unit and 66 (14.7%) were placed on mechanical ventilation. 67 patients (15%) died within the first 30 days of follow-up. In the multivariate analysis, the only independent variable predictive of mortality at 30 days was age (adjusted Odds ratio [aOR] = 1.08, 95% CI = 1.04-1.11, p <0.001). The 4C-Score and CALL-Score prognostic scores showed good discrimination (Area under the curve [AUC] = 0.766, 95% CI = 0.72-0.80 and AUC = 0.785, 95% CI = 0.70-0.85 respectively) and the predicted percentages of mortality were quite close to what was observed in the present study. Conclusions: Most of the patients hospitalized with SARS-CoV-2 infection presented comorbidities and were admitted with pneumonia, associated with high mortality. The prognostic scores with the best performance to predict complications were the 4C-score and the CALL-score. Universidad Nacional de Córdoba
Introduction: COVID-19 disease shows a marked heterogeneity in its clinical course, with descriptions of some factors associated with a worse prognosis. Knowledge of the disease behavior in the local scenario is relevant to allow a better approach. Methods: Retrospective study in two hospitals in the city of Córdoba, Argentina, with patients aged 18 years or more, hospitalized for active SARS-CoV-2 infection, from March to October, 2020. Results: 448 patients were included, of which 95.75% corresponded to COVID-19 pneumonia. Most of the episodes occurred in men (63.6%), the median age was 63 years (IQR: 53-75), and the most frequent comorbidities were arterial hypertension (55.1%), obesity (31.7%) and diabetes mellitus (28.1%). 162 patients (36.2%) needed admission to the intensive care unit and 66 (14.7%) were placed on mechanical ventilation. 67 patients (15%) died within the first 30 days of follow-up. In the multivariate analysis, the only independent variable predictive of mortality at 30 days was age (adjusted Odds ratio [aOR] = 1.08, 95% CI = 1.04-1.11, p <0.001). The 4C-Score and CALL-Score prognostic scores showed good discrimination (Area under the curve [AUC] = 0.766, 95% CI = 0.72-0.80 and AUC = 0.785, 95% CI = 0.70-0.85 respectively) and the predicted percentages of mortality were quite close to what was observed in the present study. Conclusions: Most of the patients hospitalized with SARS-CoV-2 infection presented comorbidities and were admitted with pneumonia, associated with high mortality. The prognostic scores with the best performance to predict complications were the 4C-score and the CALL-score. Universidad Nacional de Córdoba
Authors: Horacio M Castro; Hernan L Canale; Bruno L Ferreyro; Manuel A Prieto; Brenda E Massimino; Gabriel Funtowicz; Joaquín Maritano Furcada Journal: Medicina (B Aires) Date: 2020 Impact factor: 0.653
Authors: Santiago E Melendi; María M Pérez; Cintia E Salas; Mariana F Haedo; Franco B Xavier; Jandry D Saltos Navarrete; Camila Aguirre; María L Baleta; Facundo J Balsano; Mariano G Caldano; María G Colignon; Thayana de Oliveira Brasil; Nicolás de Wolodimeroff; Andrea I Déramo Aquino; Ana G Fernández de Córdova; María B Fontan; Florencia I Galvagno; Noelia S Iturrieta Araya; Volga S Mollinedo Cruz; Agustín Olivero; Ignacio Pestalardo; María Ricciardi; María L Vera Rueda; María C Villaverde; Marcela Lauko Mauri; Carlos Ujeda; Rocío Leis Journal: Medicina (B Aires) Date: 2020 Impact factor: 0.653
Authors: M J Fine; T E Auble; D M Yealy; B H Hanusa; L A Weissfeld; D E Singer; C M Coley; T J Marrie; W N Kapoor Journal: N Engl J Med Date: 1997-01-23 Impact factor: 91.245
Authors: Daniel Schönfeld; Sergio Arias; Juan Carlos Bossio; Hugo Fernández; David Gozal; Daniel Pérez-Chada Journal: PLoS One Date: 2021-02-11 Impact factor: 3.240
Authors: Ventura A Simonovich; Leandro D Burgos Pratx; Paula Scibona; María V Beruto; Marcelo G Vallone; Carolina Vázquez; Nadia Savoy; Diego H Giunta; Lucía G Pérez; Marisa Del L Sánchez; Andrea Vanesa Gamarnik; Diego S Ojeda; Diego M Santoro; Pablo J Camino; Sebastian Antelo; Karina Rainero; Gabriela P Vidiella; Erica A Miyazaki; Wanda Cornistein; Omar A Trabadelo; Fernando M Ross; Mariano Spotti; Gabriel Funtowicz; Walter E Scordo; Marcelo H Losso; Inés Ferniot; Pablo E Pardo; Eulalia Rodriguez; Pablo Rucci; Julieta Pasquali; Nora A Fuentes; Mariano Esperatti; Gerardo A Speroni; Esteban C Nannini; Alejandra Matteaccio; Hernán G Michelangelo; Dean Follmann; H Clifford Lane; Waldo H Belloso Journal: N Engl J Med Date: 2020-11-24 Impact factor: 91.245
Authors: Peter Horby; Wei Shen Lim; Jonathan R Emberson; Marion Mafham; Jennifer L Bell; Louise Linsell; Natalie Staplin; Christopher Brightling; Andrew Ustianowski; Einas Elmahi; Benjamin Prudon; Christopher Green; Timothy Felton; David Chadwick; Kanchan Rege; Christopher Fegan; Lucy C Chappell; Saul N Faust; Thomas Jaki; Katie Jeffery; Alan Montgomery; Kathryn Rowan; Edmund Juszczak; J Kenneth Baillie; Richard Haynes; Martin J Landray Journal: N Engl J Med Date: 2020-07-17 Impact factor: 91.245